Pharmaceutical Technology

MAY 15, 2023

Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry. Adeno-associated virus vectors, alcohol dehydrogenase compositions, and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing.

Antibody 130

Antibody DNA Development Vaccination 130

Rethinking Clinical Trials

AUGUST 22, 2022

Trial participants were adults ages 30-85, who tested positive for SARS-CoV-2 within 3 days, with fewer than 7 days of symptoms, no known prior infection with SARS-CoV-2, no severe kidney, liver, or heart failure. Initially, the randomization of the trial was 1:1 Metformin or Placebo. We also kept equal focus on follow-up.

Trials 130

Trials Clinical Trials Clinical Trials Insulin 130

Druggist

OCTOBER 25, 2020

Calamine lotion for chickenpox is usually considered the first choice in the management of itchiness caused by varicella-zoster virus infection. Chickenpox is a common viral infection, which usually affects children; however, it may also affect adults. In the final part of the infection, blisters scab over, forming crusted spots.

Production 52

Production Pharmacy Licensing Licensing 52

XTalks

AUGUST 17, 2020

T cell transfer or adoptive/immune cell therapy : these enhance the natural ability of T cells to fight infection, cancer or other disease processes. Immune checkpoint inhibitors : these are drugs that block immune checkpoints, allowing immune cells to elicit enhanced responses to cancer cells.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Delveinsight

DECEMBER 3, 2020

The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. of the time and negative results 99.98% of the time, as per Roche. Janssen buys a gene therapy asset.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

XTalks

JANUARY 19, 2024

This biological variability adds complexity, but with that complexity comes the power to choose the targets, the tags and the payloads and select combinations appropriate to the patient to personalize that therapy. There is also potential for using several radiotherapies in combination therapies. References The Green Journal.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

MAY 4, 2021

These assumptions are guided by the trajectory of current infection rates in many parts of the world and the expected timeline for broad access to effective vaccines. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset in Phase 2 development for the treatment of invasive fungal infections.

Vaccination 40

Vaccination Vaccine Production Sales 40